
Thomas Brown
Examiner (ID: 11072)
| Most Active Art Unit | 2601 |
| Art Unit(s) | 2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857 |
| Total Applications | 1242 |
| Issued Applications | 1062 |
| Pending Applications | 29 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8779682
[patent_doc_number] => 20130101657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'ANGIOGENESIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/627939
[patent_app_country] => US
[patent_app_date] => 2012-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24991
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627939
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/627939 | ANGIOGENESIS INHIBITORS | Sep 25, 2012 | Abandoned |
Array
(
[id] => 9607619
[patent_doc_number] => 08784782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions'
[patent_app_type] => utility
[patent_app_number] => 13/616585
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31385
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/616585 | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions | Sep 13, 2012 | Issued |
Array
(
[id] => 8904917
[patent_doc_number] => 20130172420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'LOW ENVIRONMENTAL IMPACT PESTICIDE MADE FROM \"GRAS\" INGREDIENTS FOR USE AGAINST COQUI FROGS AND OTHER SPECIES'
[patent_app_type] => utility
[patent_app_number] => 13/615117
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20016
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615117
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/615117 | Low environmental impact pesticide made from “GRAS†ingredients for use against Coqui frogs and other species | Sep 12, 2012 | Issued |
Array
(
[id] => 10289069
[patent_doc_number] => 20150174068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients'
[patent_app_type] => utility
[patent_app_number] => 14/344455
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7546
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344455
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344455 | Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients | Sep 11, 2012 | Abandoned |
Array
(
[id] => 8697819
[patent_doc_number] => 20130059828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/601572
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12682
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/601572 | PHARMACEUTICAL COMPOSITION | Aug 30, 2012 | Abandoned |
Array
(
[id] => 9581744
[patent_doc_number] => 08771745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/596904
[patent_app_country] => US
[patent_app_date] => 2012-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11872
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13596904
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/596904 | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof | Aug 27, 2012 | Issued |
Array
(
[id] => 10373133
[patent_doc_number] => 20150258139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'METHODS FOR TREATMENT OF CANCER USING LIPOPLATIN'
[patent_app_type] => utility
[patent_app_number] => 14/390352
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15989
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390352 | METHODS FOR TREATMENT OF CANCER USING LIPOPLATIN | Aug 12, 2012 | Abandoned |
Array
(
[id] => 10528136
[patent_doc_number] => 09254250
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-02-09
[patent_title] => 'Molecules to perfect HbA1c levels'
[patent_app_type] => utility
[patent_app_number] => 13/570382
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2983
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570382
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570382 | Molecules to perfect HbA1c levels | Aug 8, 2012 | Issued |
Array
(
[id] => 17140135
[patent_doc_number] => 20210308146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 13/566633
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566633
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/566633 | PHARMACEUTICAL COMPOSITION | Aug 2, 2012 | Abandoned |
Array
(
[id] => 11879541
[patent_doc_number] => 09750696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Dissolution enhanced controlled drug delivery system for poorly water soluble drugs'
[patent_app_type] => utility
[patent_app_number] => 14/236162
[patent_app_country] => US
[patent_app_date] => 2012-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236162
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236162 | Dissolution enhanced controlled drug delivery system for poorly water soluble drugs | Jul 31, 2012 | Issued |
Array
(
[id] => 8611851
[patent_doc_number] => 20130017163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/548352
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 44409
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/548352 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | Jul 12, 2012 | Abandoned |
Array
(
[id] => 8609946
[patent_doc_number] => 20130015258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Aromatic Adhesive-Backed Tab and Method of Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/549082
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4455
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549082 | Aromatic adhesive-backed tab and method of using same | Jul 12, 2012 | Issued |
Array
(
[id] => 9222562
[patent_doc_number] => 20140017337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'THERAPEUTIC METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/546202
[patent_app_country] => US
[patent_app_date] => 2012-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30564
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13546202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/546202 | THERAPEUTIC METHODS | Jul 10, 2012 | Abandoned |
Array
(
[id] => 8482944
[patent_doc_number] => 20120282352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/544949
[patent_app_country] => US
[patent_app_date] => 2012-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10557
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13544949
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/544949 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | Jul 8, 2012 | Abandoned |
Array
(
[id] => 16138863
[patent_doc_number] => 10702485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Compositions and methods for overcoming resistance to tramadol
[patent_app_type] => utility
[patent_app_number] => 13/543883
[patent_app_country] => US
[patent_app_date] => 2012-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 32
[patent_no_of_words] => 22349
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543883
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/543883 | Compositions and methods for overcoming resistance to tramadol | Jul 7, 2012 | Issued |
Array
(
[id] => 8476762
[patent_doc_number] => 20120276170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'INJECTABLE DRUG CARRIER COMPRISING LAYERED DOUBLE HYDROXIDE'
[patent_app_type] => utility
[patent_app_number] => 13/541413
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3831
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541413
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/541413 | Injectable drug carrier comprising layered double hydroxide | Jul 2, 2012 | Issued |
Array
(
[id] => 8478027
[patent_doc_number] => 20120277434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/539872
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16920
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/539872 | METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS | Jul 1, 2012 | Abandoned |
Array
(
[id] => 8417615
[patent_doc_number] => 20120245115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => '1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities'
[patent_app_type] => utility
[patent_app_number] => 13/493703
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13967
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13493703
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/493703 | 1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities | Jun 10, 2012 | Issued |
Array
(
[id] => 9656200
[patent_doc_number] => 20140227205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'TOPICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/124762
[patent_app_country] => US
[patent_app_date] => 2012-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124762
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124762 | TOPICAL COMPOSITION | Jun 5, 2012 | Abandoned |
Array
(
[id] => 8417656
[patent_doc_number] => 20120245156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'ORAL LYOPHILIZED COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/487438
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12110
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487438
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/487438 | ORAL LYOPHILIZED COMPOSITIONS | Jun 3, 2012 | Abandoned |